How big is Kewaunee Scientific Corp.?

As of Jun 18, Kewaunee Scientific Corp. has a market capitalization of 105.10 million and reported net sales of 220.02 million and a net profit of 17.82 million over the latest four quarters.

As of Jun 18, Kewaunee Scientific Corp. has a market capitalization of 105.10 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 220.02 million for the latest four quarters and a net profit of 17.82 million during the same period.<BR><BR>As of Apr 24, the shareholder's funds were 54.76 million, and total assets amounted to 134.77 million.

What does Kewaunee Scientific Corp. do?

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory and healthcare furniture products, operating in the Pharmaceuticals & Biotechnology industry. As of January 2025, it reported net sales of $67 million and a market cap of $105.10 million.

Overview:<BR>Kewaunee Scientific Corporation is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 67 Million (Quarterly Results - Jan 2025) <BR>Most recent Net Profit: 1 Million (Quarterly Results - Jan 2025) <BR>Market cap: USD 105.10 Million (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: 6.00 <BR>Debt Equity: 0.51 <BR>Return on Equity: 29.30% <BR>Price to Book: 1.73 <BR><BR>Contact Details:<BR>Address: 2700 W Front St, STATESVILLE NC: 28677 <BR>Tel: 1 704 8737202 <BR>Website: http://www.kewaunee.com/

Should I buy, sell or hold Kewaunee Scientific Corp.?

Who are in the management team of Kewaunee Scientific Corp.?

As of March 2022, the management team of Kewaunee Scientific Corp. includes Mr. David Rhind (Independent Chairman), Mr. Thomas Hull (President and CEO), and four Independent Directors: Mr. Keith Gehl, Ms. Margaret Pyle, Mr. John Russell, and Mr. Donald Shaw. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Kewaunee Scientific Corp. includes the following individuals:<BR><BR>- Mr. David Rhind, Independent Chairman of the Board<BR>- Mr. Thomas Hull, President, Chief Executive Officer, Director<BR>- Mr. Keith Gehl, Independent Director<BR>- Ms. Margaret Pyle, Independent Director<BR>- Mr. John Russell, Independent Director<BR>- Mr. Donald Shaw, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Is Kewaunee Scientific Corp. overvalued or undervalued?

As of June 30, 2025, Kewaunee Scientific Corp. is considered undervalued with a P/E ratio of 6 and strong long-term performance, despite a year-to-date return of -26.30%, contrasting with the S&P 500's 12.22% return.

As of 30 June 2025, Kewaunee Scientific Corp. has moved from expensive to attractive, indicating a shift in its valuation perspective. The company is currently considered undervalued, supported by a P/E ratio of 6, a Price to Book Value of 1.85, and an EV to EBITDA ratio of 7.61. In comparison, Pro-Dex, Inc. has a higher P/E of 14.77 and an EV to EBITDA of 10.46, while Lucid Diagnostics, Inc. shows a negative P/E, highlighting Kewaunee's relative attractiveness in its sector.<BR><BR>Despite a challenging year-to-date return of -26.30% compared to the S&P 500's 12.22%, Kewaunee has shown strong long-term performance with a 3-year return of 146.49% versus the S&P 500's 70.41%. This suggests that while recent performance has been weak, the company's long-term growth potential remains compelling.

Is Kewaunee Scientific Corp. technically bullish or bearish?

As of September 11, 2025, Kewaunee Scientific Corp. shows a mildly bearish trend despite a recent 5.85% weekly outperformance compared to the S&P 500, with year-to-date returns at -26.30% versus the S&P's 12.22%.

As of 11 September 2025, the technical trend for Kewaunee Scientific Corp. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by weekly and monthly MACD indicators both showing a mildly bearish signal, along with the Bollinger Bands indicating a mildly bearish trend on the weekly chart. The moving averages present a mildly bullish signal on the daily timeframe, but this is overshadowed by the overall bearish indicators. Additionally, the Dow Theory shows a mildly bearish stance on the monthly timeframe. <BR><BR>In terms of performance, Kewaunee has outperformed the S&P 500 over the past week with a return of 5.85% compared to 1.05%, but it has underperformed over the longer periods, with a year-to-date return of -26.30% versus the S&P 500's 12.22%.